Contrasting Collegium Pharmaceutical (NASDAQ:COLL) & Aurinia Pharmaceuticals (NASDAQ:AUPH)
Aurinia Pharmaceuticals (NASDAQ:AUPH – Get Free Report) and Collegium Pharmaceutical (NASDAQ:COLL – Get Free Report) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, valuation, analyst recommendations, profitability, earnings, dividends and risk. Insider & Institutional Ownership 36.8% of Aurinia […]
14 Oct 07:25 · The Markets Daily